Home Sectors Healthcare Latest Performance: Integer Corporation (NYSE: ITGR)

Latest Performance: Integer Corporation (NYSE: ITGR)


Integer Corporation trades as part of the medical devices industry and is part of the healthcare sector. The company CEO is Joseph W. Dziedzic. Integer Corp is the medical device outsource manufacturer serving cardiac, neuromodulation, orthopedics,vascular and surgical markets. The company’s brands include Greatbatch Medical, Lake Region Medical and Electrochem.

Previous Intraday Trading Performance:

The ITGR stock showed a previous change of 1.24% with an open at 78.47 and a close of 79.12. It reached an intraday high of 79.13 and a low of 77.17.

SeekingAlpha:  Integer Holdings Corporation (ITGR) CEO Joe Dziedzic on Q1 2019 Results – Earnings Call Transcript


The stock has a market cap of $2.6b with 32.6m shares outstanding, of which the float is 31.3m shares. Trading volume reached 357,257 shares compared to its average volume of 255,034 shares. Based on the current average volume and close price, the trading liquidity is bad, highly speculative and an investor may want to avoid this stock.

Historical Trading Performance:

Over the last five trading days, Integer Corporation shares returned 4.78% and in the past 30 trading days it returned 9.51%. Over three months, it changed -7.03%. In one year it has changed 21.07% and within that year its 52-week high was 92.62 and its 52-week low was 62.80. ITGR stock is 25.99% above its 52 Week Low.

Our calculations show a 200 day moving average of 79.03 and a 50 day moving average of 73.24. Currently ITGR stock is trading 0.11% above its 200 day moving average and may be a good opportunity to buy.

SeekingAlpha:  Integer Holdings Corporation (ITGR) CEO Joe Dziedzic on Q1 2019 Results – Earnings Call Transcript


The last annual fiscal EPS for the company was reported at 5.17 that ended on 31st of December 2018, which according to the previous close, that is a PE of 15.30. Based on 2 analyst estimates, the consensus EPS for the next quarter is 0.80. The TTM EPS is 3.77, which comes to a TTM PE of 20.99.

Below was the last reported quarterly diluted earnings per share:

1stQtr of 2019 (Reported on 05/02/2019): 0.66
4thQtr of 2018 (Reported on 02/21/2019): 0.78
3rdQtr of 2018 (Reported on 11/01/2018): 3.54
2ndQtr of 2018 (Reported on 08/02/2018): 0.61
1stQtr of 2018 (Reported on 05/03/2018): 0.25

Base on our calculations, the intrinsic value per share is 67.27, which means it may be overvalued by -17.61%.

Indicators to Watch:

Short-interest was 798,745, which was 2.45% of shares outstanding. The short-interest ratio or days-to-cover ratio was 2.87. This stock has some short interest, but it may be normal and no cause for concern if long the position.

The current calculated beta is 0.80.

Fundamental Indicators:

Based on last reported financials, the company’s return on equity is 16.87%, return on assets is 7.67%, profit margin is 14.73%, price-to-sales is 2.06 and price-to-book is 2.37.

Company Scores:

All scores are out of six:
 1  :Valuation Score
 2  :Past Performance Score
 1  :Financial Strength Score
 3  :Future Growth Score
 0  :Dividend Score
 1  :Overall Score

John Jones
Worked for several Wall Street firms: Salomon Smith Barney, UBS, and Charles Schwab. Has developed skills and gained extensive experience over the years that is used today to uncover winning penny stocks.Also was an attorney for small businesses in Scottsdale, Arizona. That experience and understanding of law provides a unique perspective and edge in discovering quality companies in various industries.